Drug Interactions Database

944 interactions from BNF 85 - Check your medicines

Source: BNF 85

Severity: All 6278 Severe 944 Moderate 1418 Unknown 3916

dabrafenib antipsychotics,secondgeneration

decreases exposure

Severe Theoretical

dabrafenib avapritinib

decreases exposure

Severe Study

dabrafenib bedaquiline

decreases exposure

Severe Study

dabrafenib cariprazine

decreases exposure

Severe Theoretical

dabrafenib cobimetinib

decreases exposure

Severe Theoretical

dabrafenib darolutamide

decreases exposure

Severe Theoretical

dabrafenib elvitegravir

decreases concentration

Severe Theoretical

dabrafenib entrectinib

decreases exposure

Severe Theoretical

dabrafenib finerenone

decreases exposure

Severe Study

dabrafenib glecaprevir

decreases exposure

Severe Study

dabrafenib grazoprevir

decreases exposure

Severe Study

dabrafenib isavuconazole

decreases exposure

Severe Theoretical

dabrafenib larotrectinib

decreases exposure

Severe Study

dabrafenib mineralocorticoidreceptorantagonists

decreases exposure

Severe Study

dabrafenib mobocertinib

decreases exposure

Severe Study

dabrafenib paclitaxel

decreases exposure

Severe Study

dabrafenib pibrentasvir

decreases exposure

Severe Study

dabrafenib rimegepant

decreases exposure

Severe Theoretical

dabrafenib selumetinib

decreases exposure

Severe Study

dabrafenib temsirolimus

decreases concentration

Severe Theoretical

dabrafenib velpatasvir

decreases exposure

Severe Theoretical

dabrafenib venetoclax

decreases exposure

Severe Study

dabrafenib voxilaprevir

decreases concentration

Severe Theoretical

dabrafenib zanubrutinib

decreases exposure

Severe Theoretical

dacomitinib betablockers,non-selective

increases exposure

Severe Study

dacomitinib betablockers,selective

increases exposure

Severe Study

dacomitinib imipramine

increases exposure

Severe Study

dacomitinib metoprolol

increases exposure

Severe Study

dacomitinib nebivolol

increases exposure

Severe Study

dacomitinib nortriptyline

increases exposure

Severe Study

dacomitinib propranolol

increases exposure

Severe Study

dacomitinib tolterodine

increases exposure

Severe Study

dacomitinib tricyclicantidepressants

increases exposure

Severe Study

darolutamide atorvastatin

increases exposure

Severe Theoretical

darolutamide fluvastatin

increases exposure

Severe Theoretical

darolutamide rosuvastatin

increases exposure

Severe Theoretical

darolutamide statins

increases exposure

Severe Theoretical

darolutamide sulfasalazine

increases exposure

Severe Theoretical

darolutamide topotecan

increases exposure

Severe Theoretical

deferasirox aminophylline

increases exposure

Severe Theoretical

deferasirox antipsychotics,secondgeneration

increases exposure

Severe Theoretical

deferasirox clozapine

increases exposure

Severe Theoretical

deferasirox meglitinides

increases exposure

Severe Study

deferasirox repaglinide

increases exposure

Severe Study

deferasirox theophylline

increases exposure

Severe Study

dexamethasone avapritinib

decreases exposure

Severe Theoretical

dexrazoxane antiepileptics

decreases absorption

Severe Theoretical

dexrazoxane fosphenytoin

decreases absorption

Severe Theoretical

dexrazoxane phenytoin

decreases absorption

Severe Theoretical

dronedarone antipsychotics,secondgeneration

increases exposure

Severe Study

Prev 1 ... 3 4 5 6 7 ... 19 Next

944 interactions

Important: This database uses data from the British National Formulary (BNF 85). It is for informational purposes only and is not a substitute for professional medical advice.